Cost-Effectiveness of Pneumococcal Vaccination among Patients with Diabetes Mellitus

Cost-Effectiveness of Pneumococcal Vaccination among Patients with Diabetes Mellitus

Relevance. Patients with diabetes mellitus have an increased risk of developing various infections, including those of the lower respiratory tract. Immunization with anti-pneumococcal vaccines reduces pneumonia-related hospitalizations and deaths.Aim. Evaluate the cost-effectiveness of vaccination a...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Rudakova, N. I. Briko, Yu. V. Lobzin, I. S. Namazova-Baranova, S. N. Avdeev, V. A. Korshunov, M. P. Kostinov, G. I. Ignatova, E. V. Blinova, A. V. Kontsevaya, R. V. Shepel, I. Yu. Drozdova, O. M. Drapkina
Format: Article
Language:Russian
Published: Numikom LLC 2022-11-01
Series:Эпидемиология и вакцинопрофилактика
Subjects:
pneumonia
vaccination
type 2 diabetes
cost-effectiveness
Online Access:https://www.epidemvac.ru/jour/article/view/1677
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items